ProfileGDS4718 / 221441_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 12% 14% 7% 10% 17% 9% 6% 24% 13% 13% 6% 10% 10% 9% 6% 13% 12% 10% 13% 5% 13% 10% 14% 17% 12% 5% 7% 5% 17% 5% 7% 2% 10% 11% 3% 9% 5% 11% 10% 12% 15% 5% 9% 6% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.8811612
GSM549102patient 115, normal, homogenized [OPG study]3.9336414
GSM549104patient 119, normal, homogenized [OPG study]3.643157
GSM549108patient 138, normal, homogenized [OPG study]3.8046610
GSM549119patient 077, normal, homogenized [OPG study]4.0419517
GSM549133patient 032, cancer, homogenized [OPG study]3.691729
GSM549139patient 042, cancer, homogenized [OPG study]3.611376
GSM549099patient 107, normal, homogenized [OPG study]4.3238124
GSM549109patient 139, normal, homogenized [OPG study]3.9325913
GSM549110patient 046, normal, homogenized [OPG study]3.9046813
GSM549114patient 063, normal, homogenized [OPG study]3.628086
GSM549122patient 082, normal, homogenized [OPG study]3.770610
GSM549134patient 033, cancer, homogenized [OPG study]3.7608310
GSM549136patient 036, cancer, homogenized [OPG study]3.714019
GSM549140patient 044, cancer, homogenized [OPG study]3.608126
GSM549111patient 047, normal, homogenized [OPG study]3.8747313
GSM549113patient 057, normal, homogenized [OPG study]3.8037712
GSM549132patient 031, cancer, homogenized [OPG study]3.7874310
GSM549137patient 038, cancer, homogenized [OPG study]3.884113
GSM549142patient 047, cancer, homogenized [OPG study]3.640055
GSM549100patient 110, normal, homogenized [OPG study]3.8978213
GSM549107patient 135, normal, homogenized [OPG study]3.7569710
GSM549115patient 068, normal, homogenized [OPG study]3.8826814
GSM549116patient 072, normal, homogenized [OPG study]4.0151217
GSM549120patient 078, normal, homogenized [OPG study]3.8441612
GSM549131patient 030, cancer, homogenized [OPG study]3.557745
GSM549118patient 074, normal, homogenized [OPG study]3.692377
GSM549129patient 027, cancer, homogenized [OPG study]3.615585
GSM549123patient 088, normal, homogenized [OPG study]4.0311617
GSM549124patient 006, cancer, homogenized [OPG study]3.602345
GSM549126patient 015, cancer, homogenized [OPG study]3.636627
GSM549128patient 025, cancer, homogenized [OPG study]3.423312
GSM549103patient 117, normal, homogenized [OPG study]3.8076510
GSM549117patient 073, normal, homogenized [OPG study]3.8191611
GSM549138patient 041, cancer, homogenized [OPG study]3.453633
GSM549141patient 045, cancer, homogenized [OPG study]3.708669
GSM549130patient 028, cancer, homogenized [OPG study]3.570395
GSM549101patient 111, normal, homogenized [OPG study]3.8277711
GSM549105patient 128, normal, homogenized [OPG study]3.7898410
GSM549106patient 134, normal, homogenized [OPG study]3.8092912
GSM549112patient 048, normal, homogenized [OPG study]3.9415215
GSM549125patient 011, cancer, homogenized [OPG study]3.56175
GSM549127patient 024, cancer, homogenized [OPG study]3.715869
GSM549135patient 035, cancer, homogenized [OPG study]3.60366